Titan Medical Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Titan Medical Inc (TMDI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Titan Medical Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 20M vs 52M combined for tracked competitors (27.8% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
- Peer revenue share: Titan Medical Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
TMDI Sales vs. its Competitors, Q4 2021
Titan Medical Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
Titan Medical Inc vs. its Competitors, Q4 2021
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Titan Medical Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Titan Medical Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (2) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Titan Medical Inc's competitor groups requires a Commercial License.
For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs 100.9% for Titan Medical Inc. Titan Medical Inc's share of combined industry revenue moved from 0.01% to 0.02%, a gain of 0.01 percentage points.
Titan Medical Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Titan Medical Inc | - | - | - | - |
| Competitors combined (2) | ||||
| High-Confidence Competitors (2) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
TMDI Stock Performance relative to its Competitors
TMDI Stock Performance relative to High-Confidence Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Vicarious Surgical Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Titan Medical Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Publicly Traded Peers of Titan Medical Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Titan Medical Inc | - | 20.09 |
| Vicarious Surgical Inc | 0.44 | - |
| Ss Innovations International Inc | - | 52.20 |
| SUBTOTAL | 0.44 | 72.29 |
Sources: Titan Medical Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Titan Medical Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Titan Medical Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Ss Innovations International Inc | Named by the company | 85% |
| Meere Company | Named by the company | 85% |
| Intuitive Surgical Inc | Named by the company | 85% |
| Vicarious Surgical Inc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Titan Medical Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Titan Medical Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Titan Medical Inc | - | - | - |
| Vicarious Surgical Inc | 0 | - | -1,619,885 |
| Ss Innovations International Inc | - | 108,071 | -24,835 |
| PEERS TOTAL | 0 | 102,551 | -106,311 |
Titan Medical Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Ss Innovations International Inc | IN 98.66 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Titan Medical Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Weaknesses
No rule matched.
Opportunities
- A meaningful share of tracked competitors (50.00 %) show financial-distress signals, a possible opening to gain share.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Titan Medical Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Titan Medical Inc | 2.97 | 4.01 | - |
| Vicarious Surgical Inc | 0.71 | 3.73 | 0.02 |
| Ss Innovations International Inc | 0.37 | 2.23 | 0.26 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Titan Medical Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Titan Medical Inc | Q4 2021 | +0.5 % | - |
| Vicarious Surgical Inc | Q1 2026 | - | - |
| Ss Innovations International Inc | Q2 2026 | +39.4 % | - |
| PEERS TOTAL | +13.4 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Titan Medical Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Titan Medical Inc | Q4 2021 | - | +32.1 % |
| Vicarious Surgical Inc | Q1 2026 | - | +80.0 % |
| Ss Innovations International Inc | Q2 2026 | +67.4 % | +335,047.9 % |
Titan Medical Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Titan Medical Inc | - | - | - |
| Vicarious Surgical Inc | - | - | - |
| Ss Innovations International Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Titan Medical Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Titan Medical Inc | - | - |
| Vicarious Surgical Inc | - | - |
| Ss Innovations International Inc | - | - |
| PEERS AVERAGE | - | 0.01 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.